Intralipid therapy is primarily indicated in cases of severe toxicity from lipophilic drugs, particularly when standard treatments are ineffective. Common indications include overdose with local anesthetics such as bupivacaine and ropivacaine, but it has also been used in poisonings involving other lipophilic agents like tricyclic antidepressants, beta-blockers, and calcium channel blockers.
